Description
What it is / How it works
Dual GLP-1/glucagon receptor agonist.
Common research interest
Obesity, metabolic health, appetite and metabolic liver disease.
Evidence / status
Investigational with ongoing human clinical development.
A dual glucagon and GLP-1 receptor agonist studied for appetite regulation, metabolic function, glucose control, and body-weight management in clinical research. Premium Research Peptide.